Yoshinari Nagakane

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Standard-Dose Tenecteplase vs Low-Dose Alteplase for Acute Ischemic Stroke From Large-Vessel Occlusion: A Randomized Clinical Trial.

Standard-Dose Tenecteplase vs Low-Dose Alteplase for Acute Ischemic Stroke From Large-Vessel Occlusion: A Randomized Clinical Trial.

Journal: JAMA neurology

Published: June 01, 2026

Impact of Basal Ganglia Perivascular Spaces on Ischemic and Hemorrhagic Risks in Patients Taking Antithrombotic Therapies.

Impact of Basal Ganglia Perivascular Spaces on Ischemic and Hemorrhagic Risks in Patients Taking Antithrombotic Therapies.

Journal: Neurology

Published: March 20, 2026

Development and Validation of a Machine Learning Model to Predict Oral Anticoagulant Use in Stroke From Prothrombin Time-International Normalized Ratio and Activated Partial Thromboplastin Time.

Development and Validation of a Machine Learning Model to Predict Oral Anticoagulant Use in Stroke From Prothrombin Time-International Normalized Ratio and Activated Partial Thromboplastin Time.

Journal: Journal of the American Heart Association

Published: March 18, 2026

Long-term Risk of Bleeding Events in Patients Taking Antithrombotic Agents for Cerebrovascular or Cardiovascular Disease.

Long-term Risk of Bleeding Events in Patients Taking Antithrombotic Agents for Cerebrovascular or Cardiovascular Disease.

Journal: International journal of stroke : official journal of the International Stroke Society

Published: February 27, 2026

Impact of Intracranial Atherosclerosis and Cerebral Small Vessel Disease on Overt Vascular Events During Antithrombotic Therapy.

Impact of Intracranial Atherosclerosis and Cerebral Small Vessel Disease on Overt Vascular Events During Antithrombotic Therapy.

Journal: European journal of neurology

Published: December 24, 2025

Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.

Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.

Journal: Lancet (London, England)

Published: December 06, 2025

A case of treatment-related leukoencephalopathy during combination therapy with daratumumab, lenalidomide, and low-dose dexamethasone for multiple myeloma

A case of treatment-related leukoencephalopathy during combination therapy with daratumumab, lenalidomide, and low-dose dexamethasone for multiple myeloma

Journal: Rinsho shinkeigaku = Clinical neurology

Published: July 24, 2025

Prediction Model to Optimize Long-Term Antithrombotic Therapy Using Covert Vascular Brain Injury and Clinical Features.

Prediction Model to Optimize Long-Term Antithrombotic Therapy Using Covert Vascular Brain Injury and Clinical Features.

Journal: Stroke

Published: June 19, 2025

Identification of potential embolic source and consideration for ischemic lesion formation using the consecutive patient registry of acute embolic stroke

Identification of potential embolic source and consideration for ischemic lesion formation using the consecutive patient registry of acute embolic stroke

Journal: Rinsho shinkeigaku = Clinical neurology

Published: February 26, 2025

Clinical Characteristics of Ischemic Stroke in Japanese Young Adults.

Clinical Characteristics of Ischemic Stroke in Japanese Young Adults.

Journal: Cerebrovascular diseases extra

Published: December 30, 2024

Administration of Cilostazol Prior to Intravenous Alteplase for Acute Branch Atheromatous Disease: A Report of Three Cases.

Administration of Cilostazol Prior to Intravenous Alteplase for Acute Branch Atheromatous Disease: A Report of Three Cases.

Journal: Case reports in neurological medicine

Published: December 12, 2024

Five-year outcomes in patients with ischemic stroke or transient ischemic attack after widespread use of direct oral anticoagulants

Five-year outcomes in patients with ischemic stroke or transient ischemic attack after widespread use of direct oral anticoagulants

Journal: Rinsho shinkeigaku = Clinical neurology

Published: October 14, 2024

Showing 1-12 of 64

Last Updated: 09/26/2026